Adler AI[au] - Search Results

Year	Number of Results
1992	1
1993	1
1994	1
1995	2
1996	2
1997	2
1998	2
1999	3
2000	2
2001	2
2002	3
2003	2
2004	1
2005	4
2006	3
2007	1
2008	4
2009	6
2010	7
2011	3
2012	11
2013	8
2014	8
2015	5
2016	5
2017	6
2018	3
2019	6
2020	2
2021	8
2022	10
2023	2
2024	1

1

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Stratton IM, et al. Among authors: adler ai. BMJ. 2000 Aug 12;321(7258):405-12. doi: 10.1136/bmj.321.7258.405. BMJ. 2000. PMID: 10938048 Free PMC article.

2

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR; UKPDS GROUP. Adler AI, et al. Kidney Int. 2003 Jan;63(1):225-32. doi: 10.1046/j.1523-1755.2003.00712.x. Kidney Int. 2003. PMID: 12472787 Free article. Clinical Trial.

3

Incretins and cancer of the bile duct in type 2 diabetes.

Adler AI. Adler AI. BMJ. 2018 Dec 6;363:k5155. doi: 10.1136/bmj.k5155. BMJ. 2018. PMID: 30522996 No abstract available.

4

The diabetes prevention program.

Adler AI, Turner RC. Adler AI, et al. Diabetes Care. 1999 Apr;22(4):543-5. doi: 10.2337/diacare.22.4.543. Diabetes Care. 1999. PMID: 10189529 Review. No abstract available.

5

Ocrelizumab for primary progressive multiple sclerosis.

Adler AI, Knight H. Adler AI, et al. Lancet Neurol. 2019 Sep;18(9):816-817. doi: 10.1016/S1474-4422(19)30245-5. Epub 2019 Jul 3. Lancet Neurol. 2019. PMID: 31279744 No abstract available.

6

Insulin resistance and incident heart failure: a meta-analysis.

Erqou S, Adler AI, Challa AA, Fonarow GC, Echouffo-Tcheugui JB. Erqou S, et al. Among authors: adler ai. Eur J Heart Fail. 2022 Jun;24(6):1139-1141. doi: 10.1002/ejhf.2531. Epub 2022 May 16. Eur J Heart Fail. 2022. PMID: 35502564 Free PMC article. No abstract available.

7

Glucocorticoid-induced hyperglycaemia in respiratory disease: a systematic review and meta-analysis.

Breakey S, Sharp SJ, Adler AI, Challis BG. Breakey S, et al. Among authors: adler ai. Diabetes Obes Metab. 2016 Dec;18(12):1274-1278. doi: 10.1111/dom.12739. Epub 2016 Aug 4. Diabetes Obes Metab. 2016. PMID: 27392119 Free PMC article. Review.

8

Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.

Bethel MA, Sourij H, Stevens SR, Hannan K, Lokhnygina Y, Adler AI, Peterson ED, Holman RR, Lopes RD. Bethel MA, et al. Among authors: adler ai. Cardiovasc Diabetol. 2023 Mar 28;22(1):72. doi: 10.1186/s12933-023-01802-x. Cardiovasc Diabetol. 2023. PMID: 36978066 Free PMC article. Clinical Trial.

9

Endpoints and estimands: understanding trials of weight-loss drugs.

Adler AI. Adler AI. Nat Med. 2022 Oct;28(10):2005-2006. doi: 10.1038/s41591-022-02032-6. Nat Med. 2022. PMID: 36216946 No abstract available.

10

Micronutrients and diabetic retinopathy a systematic review.

Lee CT, Gayton EL, Beulens JW, Flanagan DW, Adler AI. Lee CT, et al. Among authors: adler ai. Ophthalmology. 2010 Jan;117(1):71-8. doi: 10.1016/j.ophtha.2009.06.040. Epub 2009 Nov 8. Ophthalmology. 2010. PMID: 19900709 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

114 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year